Aeglea BioTherapeutics to Participate in Two Upcoming Virtual Investor Conferences

AUSTIN, Texas, Nov. 17, 2020 /PRNewswire/ -- Aeglea BioTherapeutics, Inc. (NASDAQ: AGLE), a clinical-stage biotechnology company developing a new generation of human enzyme therape…